News
Modern Retina provides ophthalmology professionals with the latest advancements, research, and expert insights in retinal ...
Newsletter Keep your retina practice on the forefront—subscribe for expert analysis and emerging trends in retinal disease management.
Sanofi's SAR446597 receives FDA fast track designation, offering a promising one-time gene therapy for geographic atrophy and reducing treatment frequency.
Discover how AI transforms eye care with innovative tools for managing age-related macular degeneration, enhancing treatment efficiency and patient outcomes.
Advertorial: Could targeting retinal non-perfusion be the key to achieving true disease modification in diabetic retinopathy? The triad of inflammation, neuropathy, and vasculopathy plays a key role ...
The survey shows the evolving landscape of nAMD and DME treatments, highlighting physician preferences, payer influences, and the promise of gene therapy advancements.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results